Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF-1α/HK2 pathway
- PMID: 37655539
- DOI: 10.1002/ptr.7988
Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF-1α/HK2 pathway
Erratum in
-
Correction to "Ginkgo biloba Extract Promotes Treg Differentiation to Ameliorate Ischemic Stroke via Inhibition of HIF-1α/HK2 Pathway".Phytother Res. 2025 Sep 22. doi: 10.1002/ptr.70093. Online ahead of print. Phytother Res. 2025. PMID: 40984687 No abstract available.
Abstract
The ischemic brain can dialogue with peripheral tissues through the immune system. Ginkgo biloba extract (EGb) was used to regulate various neurological disorders; however, the impact of EGb on ischemic stroke is still unclear. Here, we aimed to investigate whether immunomodulation has participated in the beneficial effects of EGb on ischemia/reperfusion (I/R) brain injury. Mice were orally administered with EGb once daily for 7 days before the induction of I/R. Neurobehavioral scores, infarct volume, and brain inflammation were determined. The proportion of CD4+ T cells was detected by flow cytometry. EGb significantly lowered neurobehavioral scores, infarct volume, and the level of inflammatory cytokines in I/R mice. Interestingly, EGb altered the proportion of CD4+ T cells, particularly increasing the proportion of Treg cells. Depletion of Treg cells weakened the neuroprotective effects of EGb on ischemic stroke; furthermore, EGb decreased the expression of HIF-1α and HK2 and promoted the differentiation of Treg cells in vitro. EGb suppressed the HIF-1α/HK2 signaling pathway to promote the differentiation of Treg cells and ameliorate ischemic stroke in mice. The expansion effect of EGb on Treg cells could be exploited as part of future stroke therapy.
Keywords: Ginkgo biloba extract; HIF-1α/HK2; Treg cells; glycolysis; ischemic stroke.
© 2023 John Wiley & Sons, Ltd.
References
REFERENCES
-
- Ahlemeyer, B., & Krieglstein, J. (2003). Neuroprotective effects of Ginkgo biloba extract. Cellular and Molecular Life Sciences, 60(9), 1779-1792. https://doi.org/10.1007/s00018-003-3080-1
-
- An, C., Shi, Y., Li, P., Hu, X., Gan, Y., Stetler, R. A., Leak, R. K., Gao, Y., Sun, B. L., Zheng, P., & Chen, J. (2014). Molecular dialogs between the ischemic brain and the peripheral immune system: Dualistic roles in injury and repair. Progress in Neurobiology, 115, 6-24. https://doi.org/10.1016/j.pneurobio.2013.12.002
-
- Cao, L., Wang, M., Dong, Y., Xu, B., Chen, J., Ding, Y., Qiu, S., Li, L., Karamfilova Zaharieva, E., Zhou, X., & Xu, Y. (2020). Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2. Cell Death & Disease, 11(2), 145. https://doi.org/10.1038/s41419-020-2336-0
-
- Chen, F., Li, L., Xu, F., Sun, Y., Du, F., Ma, X., Zhong, C., Li, X., Wang, F., Zhang, N., & Li, C. (2013). Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration. British Journal of Pharmacology, 170(2), 440-457. https://doi.org/10.1111/bph.12285
-
- Clark, W. M., Rinker, L. G., Lessov, N. S., Lowery, S. L., & Cipolla, M. J. (2001). Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke, 32(4), 1000-1004. https://doi.org/10.1161/01.str.32.4.1000
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials